RAMM Pharma Corp.
RAMM
CNSX
Weiss Ratings | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.39 | |||
Price History | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 33.33% | |||
60-Day Total Return | 100.00% | |||
90-Day Total Return | 100.00% | |||
Year to Date Total Return | 33.33% | |||
1-Year Total Return | -33.33% | |||
2-Year Total Return | -77.78% | |||
3-Year Total Return | -92.86% | |||
5-Year Total Return | -96.00% | |||
52-Week High % Change | -69.23% | |||
52-Week Low % Change | 300.00% | |||
Price | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.07 | |||
52-Week Low Price | $0.01 | |||
52-Week Low Price (Date) | Dec 16, 2024 | |||
52-Week High Price (Date) | Apr 04, 2024 | |||
Valuation | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.66M | |||
Enterprise Value | 1.22M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.05 | |||
Earnings Per Share Growth | -56.05% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.73 | |||
Price/Book (Q) | 0.13 | |||
Enterprise Value/Revenue (TTM) | 0.24 | |||
Price | $0.02 | |||
Enterprise Value/EBITDA (TTM) | -0.18 | |||
Enterprise Value/EBIT | -0.16 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 119.39M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416 848 7744 | |||
Address | 200, 82 Richmond St. East Toronto, ON M5C 1P1 | |||
Website | -- | |||
Country | Canada | |||
Year Founded | 1987 | |||
Profitability | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -152.82% | |||
Profit Margin | -198.82% | |||
Management Effectiveness | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -13.37% | |||
Return on Equity | -- | |||
Income Statement | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 3.29M | |||
Total Revenue (TTM) | 3.29M | |||
Revenue Per Share | $0.03 | |||
Gross Profit (TTM) | 369.60K | |||
EBITDA (TTM) | -4.36M | |||
EBIT (TTM) | -5.03M | |||
Net Income (TTM) | -6.54M | |||
Net Income Avl. to Common (TTM) | -6.54M | |||
Total Revenue Growth (Q YOY) | -11.53% | |||
Earnings Growth (Q YOY) | 6.81% | |||
EPS Diluted (TTM) | -0.05 | |||
EPS Diluted Growth (Q YOY) | 6.15% | |||
Balance Sheet | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.09M | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | 4.48M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 18.48M | |||
Current Ratio (Q) | 3.475 | |||
Book Value Per Share (Q) | $0.15 | |||
Total Assets (Q) | 19.84M | |||
Total Current Liabilities (Q) | 1.29M | |||
Total Debt (Q) | 179.10K | |||
Total Liabilities (Q) | 1.36M | |||
Total Common Equity (Q) | 18.48M | |||
Cash Flow | RAMM - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 72.80K | |||
Cash from Financing (TTM) | -151.00K | |||
Net Change in Cash (TTM) | -3.57M | |||
Levered Free Cash Flow (TTM) | -1.47M | |||
Cash from Operations (TTM) | -3.51M | |||